LPA and familial hypercholesterolemia: The uncertainties regarding the strategy to handle elevated Lp(a), particularly in patients with concomitant hypercholesterolemia, have paved the way to review the present-day evidence on the role of elevated Lp(a) in this high-risk condition, as well as on the relative value of different therapeutic approaches, i.e., from LA to upcoming RNA-based therapeutics.